Type 2 Diabetes Clinical Trial
Official title:
Effect of High-Intensity Intermittent Exercise on Abdominal Fat Mass in Type 2 Diabetes Postmenopausal Women.
Postmenopausal women, as men, are more prone to central or android obesity. Abdominal fat
mass is associated with an increase of cardiovascular diseases (CVD). In type 2 diabetic
(T2D) patients, the risk of CVD mortality is more than double compared with that in
age-matched subjects.
Most exercise programs designed for weight loss have focused on steady-state exercise (SEE)
of around 30 min at a moderate intensity several times a week. Disappointingly, these kinds
of exercise programs have led to little or no fat loss (Shaw et al. 2006). Accumulating
evidence suggests that high intensity intermittent exercise (HIIE) has the potential to be
an effective exercise protocol for reducing fat of overweight individuals, especially at the
abdominal level (Boutcher 2011, Kessler 2012). Despite these results, HIIE program has never
been used in TD2 postmenopausal women to favor a specific decrease of abdominal fat mass.
The aim of our study was to compare the effects of 16-week steady-state exercise (SSE)
program with high intensity intermittent exercise (HIIE) program on total abdominal and
visceral fat mass in T2D postmenopausal women.
It is hypothesized that HIIE compared to SSE program would result in significantly greater
reductions in total abdominal and visceral fat mass.
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | December 2017 |
Est. primary completion date | July 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 55 Years to 82 Years |
Eligibility |
Inclusion Criteria: - postmenopausal women (55- 82 years) - T2D - BMI = 25 and < 40 - able to follow an exercise protocol - eating behavior and physical activity stable since at least 3 month Exclusion Criteria: - - subject not able to perform exercise after medical examination - subject not able to perform bicycle exercise (pains) - chronic infection - use of ß-blocker - medical treatment that could interfere with the different outcome measures - Hormonal Replacement Therapy (HRT) - regular consumption of alcohol - refusal to sign the consent form |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
France | Chu Clermont Ferrand | Clermont-Ferrand |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand | Laboratory of metabolic adaptation to exercise under Physiological and Physiopathological conditions (AME2) |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | loss of abdominal fat mass (g) | Total abdominal fat mass will be measured in all patients from DXA using the methodology of Martin et Jensen (1991; L1-L2 to pubic rami) before (baseline, T0) and after 4 months of training (T4). | at baseline (T0) and after 4 months of training (T4) | Yes |
Secondary | Change from baseline in visceral fat mass (g) | calculated from computer tomography, Sottier et al. 2013 | at baseline (T0) and after 4 months of training (T4) | Yes |
Secondary | Change from baseline in total fat mass (g) determined from DXA | determined from DXA | at baseline (T0) and after 4 months of training (T4) | Yes |
Secondary | Change from baseline in total fat free mass (g) determined from DXA | determined from DXA | at baseline (T0) and after 4 months of training (T4) | Yes |
Secondary | Change from baseline in glycemic profile (plasma HbA1c and plasma glucose measurements) | plasma HbA1c and plasma glucose measurements | at T0 and after 4 months of training (T4) | Yes |
Secondary | Change from baseline in lipid profile (plasma TG, HDL, LDL and total cholesterol measurements) | plasma TG, HDL, LDL and total cholesterol measurements | at baseline (T0) and after 4 months of training (T4) | Yes |
Secondary | Change from baseline in food behavior after training (visual analog scale from Flint et al. 2000) | visual analog scale from Flint et al. 2000 | at baseline (T0) and after 4 months of training (T4) | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |